Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |